The Michael Glickman Lab

The Michael Glickman Lab

We are broadly interested in the biology of mycobacteria, which include the major human pathogen M. tuberculosis, the nonpathogenic model organism M. smegmatis, and the cancer biotherapeutic agent BCG.

Learn more
Pictured: Michael Glickman

Michael S. Glickman, MD


Research Focus

Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including regulated intramembrane proteolysis (the Rip1 pathway); double-strand-break repair and associated DNA damage responses; and cell envelope biosynthesis.


MD, Columbia University College of Physicians and Surgeons


  • Landry, D.W., Zhao, K., Yang, G.X., Glickman, M., and Georgiadis, T.M. 1993. Antibody- catalyzed degradation of cocaine. Science 259:1899-1901.
  • Glickman, M., and Klein, R.S. 1997. Acute epiglottitis due to Pasteurella multocida in an adult without animal exposure. Emerg Infect Dis 3:408-409.
Learn more